Levobupivacaine is the (S)-(-)-enantiomer of bupivacaine. Among its listed roles, it functions as a local anaesthetic, an adrenergic antagonist, an amphiphile, an EC 3.1.1.8 (cholinesterase) inhibitor and an EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor. It is the conjugate base of levobupivacaine(1+). It is an enantiomer of a dextrobupivacaine. It is grouped under the following drug class(es): Amide local anesthetics. Its therapeutic use is listed as analgesics and anesthetics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Novabupi and (-)-Bupivacaine. Its PubChem CID is 92253.
Levobupivacaine
| CAS No | 27262-47-1 |
|---|---|
| Molecular Formula | C18H28N2O |
| Molecular Weight | 288.4 g/mol |
| Synonyms | (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Levobupivacaine is the (S)-(-)-enantiomer of bupivacaine. 8 (Ca(2+)-transporting ATPase) inhibitor. It is the conjugate base of levobupivacaine(1+). It is an enantiomer of a dextrobupivacaine.
The listed CAS number is 27262-47-1.
The listed molecular formula is C18H28N2O.
The listed molecular weight is 288.4 g/mol.
(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide.
The source lists Novabupi and (-)-Bupivacaine.